Nextgen Group
From ADVFN StockWiki
 | |
| Type | Public limited company |
|---|---|
| Industry | Pharmaceuticals & Biotechnology |
| Trades as | LSE:NGG |
| Website | www.nextgensciences.com |
NextGen develops quantitative protein assays using mass spectrometry technology employed in the oncology and central nervous system (CNS) biomarker markets. [1]
News
- NextGen Group IP Filing Stirs Investor Interest - ADVFN News - March 13, 2012
- NextGen Group moves to become Patents holder - 22 February 2012
Directors
- Klaus Rosenau - Chairman & Chief Executive Officer
- Leif Hamø - Chief Financial Officer
- Barry McAleer, PhD, MBA - Director & CEO, NextGen Sciences Inc.
- Thomas Borcholte, PhD - Non-Executive Director
